missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Purvalanol B

Click to view available options
Quantity:
10 mg
50 mg
Unit Size:
10mg
50mg
Description
Purvalanol B is a cyclin-dependent kinase (cdk) inhibitor (reported IC50 values are 6 nM for cdk1 and cdk5, and 6 - 9 nM for cdk2, depending on binding partner). Purvalanol B is selective over a range of other protein kinases (IC50 >10,000 nM). Purvalanol B shows antiproliferative properties, mediated by ERK1 and ERK2. Purvalanol B induces autophagy in cellular models and induces apoptosis in cancer cells, the apoptotic effects can be increased by combining with Rapamycin (Cat. No. 1292).
Specifications
Specifications
| Quantity | 10 mg |
| Formula Weight | 432.91 |
| Purity | >99% |
| Molecular Weight (g/mol) | 432.909 |
| Chemical Name or Material | Purvalanol B |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction